396 related articles for article (PubMed ID: 33722705)
1. Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER
Amaral C; Trouille FM; Almeida CF; Correia-da-Silva G; Teixeira N
J Steroid Biochem Mol Biol; 2021 Jun; 210():105876. PubMed ID: 33722705
[TBL] [Abstract][Full Text] [Related]
2. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a multi-target compound for estrogen receptor-positive (ER
Almeida CF; Teixeira N; Oliveira A; Augusto TV; Correia-da-Silva G; Ramos MJ; Fernandes PA; Amaral C
Biochimie; 2021 Feb; 181():65-76. PubMed ID: 33278557
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
Nahler G
Pharmaceut Med; 2022 Apr; 36(2):99-129. PubMed ID: 35244889
[TBL] [Abstract][Full Text] [Related]
6. Beyond THC and Endocannabinoids.
Pacher P; Kogan NM; Mechoulam R
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():637-659. PubMed ID: 31580774
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors.
Almeida CF; Teixeira N; Valente MJ; Vinggaard AM; Correia-da-Silva G; Amaral C
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173983
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor efficacy of new 7α-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells.
Amaral C; Varela CL; Maurício J; Sobral AF; Costa SC; Roleira FMF; Tavares-da-Silva EJ; Correia-da-Silva G; Teixeira N
J Steroid Biochem Mol Biol; 2017 Jul; 171():218-228. PubMed ID: 28396197
[TBL] [Abstract][Full Text] [Related]
9. New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death.
Cepa M; Correia-da-Silva G; da Silva EJ; Roleira FM; Borges M; Teixeira NA
BMC Cell Biol; 2008 Jul; 9():41. PubMed ID: 18652661
[TBL] [Abstract][Full Text] [Related]
10. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.
De Petrocellis L; Ligresti A; Schiano Moriello A; Iappelli M; Verde R; Stott CG; Cristino L; Orlando P; Di Marzo V
Br J Pharmacol; 2013 Jan; 168(1):79-102. PubMed ID: 22594963
[TBL] [Abstract][Full Text] [Related]
11. An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER
Amaral C; Correia-da-Silva G; Almeida CF; Valente MJ; Varela C; Tavares-da-Silva E; Vinggaard AM; Teixeira N; Roleira FMF
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677847
[TBL] [Abstract][Full Text] [Related]
12. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
13. Unveiling the angiogenic effects of cannabinoids: Enhancers or inhibitors?
Maia J; Fonseca BM; Teixeira N; Correia-da-Silva G
Biochem Pharmacol; 2023 Sep; 215():115686. PubMed ID: 37463627
[TBL] [Abstract][Full Text] [Related]
14. Differential biological effects of aromatase inhibitors: Apoptosis, autophagy, senescence and modulation of the hormonal status in breast cancer cells.
Augusto TV; Amaral C; Almeida CF; Teixeira N; Correia-da-Silva G
Mol Cell Endocrinol; 2021 Nov; 537():111426. PubMed ID: 34391846
[TBL] [Abstract][Full Text] [Related]
15. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation.
Masuda H; Otsuka F; Matsumoto Y; Takano M; Miyoshi T; Inagaki K; Shien T; Taira N; Makino H; Doihara H
Mol Cell Endocrinol; 2011 Aug; 343(1-2):7-17. PubMed ID: 21664418
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid-induced changes in respiration of brain mitochondria.
Fišar Z; Singh N; Hroudová J
Toxicol Lett; 2014 Nov; 231(1):62-71. PubMed ID: 25195527
[TBL] [Abstract][Full Text] [Related]
17. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.
Houser SJ; Eads M; Embrey JP; Welch SP
Brain Res; 2000 Feb; 857(1-2):337-42. PubMed ID: 10700588
[TBL] [Abstract][Full Text] [Related]
18. Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.
Fraguas-Sánchez AI; Fernández-Carballido A; Torres-Suárez AI
Expert Opin Investig Drugs; 2016 Nov; 25(11):1311-1323. PubMed ID: 27633508
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis.
Fonseca BM; Correia-da-Silva G; Teixeira NA
J Physiol Biochem; 2018 May; 74(2):261-272. PubMed ID: 29441458
[TBL] [Abstract][Full Text] [Related]
20. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]